← 返回首页
markets
Gilead to Buy Ouro Medicines for Its Autoimmune Drugs
📍 feeds.bloomberg.com
⏰ 2026-03-23 18:20
🌏 US
Gilead Sciences Inc. said it would acquire Ouro Medicines, a closely held company testing novel antibody drugs against autoimmune diseases, for as much as $2.18 billion.